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Chapter 1  
Introduction 
 
 
 
1.1. Follicle Development: The ‘‘Two Cells–Two Gonadotropins’’ 
Theory 
Ovarian follicular maturation from the small antral follicle stage to a pre‐ovulatory 
graafian follicle requires the combined actions of two gonadotrophins: Follicle-
stimulating hormone (FSH) and Luteinizing hormone (LH). [Figure 1] 
 
Fig. 1 The Two Cell Two Gonadotrophin Theory (from Fauci et al., 17
th
 Edition Harrison’s 
Principles of Internal Medicine) 
At the beginning of each menstrual cycle, follicle recruitment and growth depends on a 
particular serum level of FSH, below which follicular development will stop (Brown, 
1978; Scheele et al., 1993; Fauser and Van Heusden, 1997). This has been defined as the 
‘FSH threshold’. The FSH threshold evolves during follicular growth, with the FSH 
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requirement being highest at the early antral stage before declining during the late 
antral stage (Scheele et al., 1993; Fauser and Van Heusden, 1997). 
FSH is a pleiotropic hormone produced by the pituitary and exerts its action on the 
ovary by inducing proliferation, differentiation and steroidogenesis in the granulosa cells 
of growing pre-ovulatory follicles. The initial development of primordial follicles (PF) is 
believed to be FSH independent (Garor et al., 2009). 
At the same time, FSH acts as a survival factor during PF transition to primary/secondary 
follicles in serum-free ovarian cortical tissue culture (Wright et al., 1999). Studies in 
hamster using anti-FSH antibodies have shown that FSH action is also required for 
formation of primordial follicles (Roy et al., 2000). They showed that a single dose of FSH 
specific polyclonal antibody during gestational period could significantly affect the 
number of primordial follicles after birth. Demeestere et al. recently concluded that FSH 
possibly coordinates development of both germline and somatic compartments of the 
mouse follicle (Demeestere et al., 2012).  
Several published reports using ovarian tissue or immortalized ovarian epithelial cell 
lines show that besides granulosa cells, FSH receptors (FSHR) are also localized on the 
normal ovary surface epithelium (Zheng et al., 1996; Ji et al., 2004; Parrott et al., 2001). 
Oocytes have also been reported to express FSHR. FSHR mRNA was detected in the 
oocytes and cleavage stage mouse embryos (Patsoula et al., 2001). FSHR is reported to 
be 20 fold higher in the human oocytes compared to granulosa cells (Méduri et 
al., 2002). 
Although follicular growth can be induced by FSH in the total absence of LH, the 
resulting follicles have developmental deficiencies such as abnormally low production of 
estradiol (E2) and an inability to luteinize and rupture in response to an hCG 
stimulus (Couzinet et al., 1988; Glasier et al., 1988; Shoham et al., 1991b; Shoham et al., 
1993; Schoot et al., 1994; European Recombinant Human LH Study Group, 
1998; Loumaye and O’Dea, 2002; Hemsey et al., 2001). Optimal follicular development is 
therefore also dependent on a minimal exposure to LH or ‘LH threshold’.  
LH, whose receptors (LHR) are expressed in granulosa cells under the influence of FSH, 
plays an important role in the regulation of ovarian function and is essential to promote 
the growth of the dominant follicle, final oocyte maturation, as well as ovulation 
induction.  
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LH promotes the production of androgens (dehydroepiandrosterone, androstenedione, 
and testosterone) from cholesterol and pregnenolone, by stimulating 17α-hydroxylase 
activity in the thecal cells. The androgens then diffuse to the granulosa cells where FSH 
stimulates the expression of the cytochrome P450 aromatase, which converts the 
androgens to estrogens [Figure 2]. 
Pre‐clinical evidence has also accumulated suggesting that developing follicles have 
finite requirements for exposure to LH, beyond which normal maturation (Hillier, 1994); 
moreover clinical testing in patients suffering from severe deficiency in LH and FSH has 
demonstrated that serum LH levels of ≥1.2 IU/l are necessary to provide adequate LH 
support to FSH‐induced follicular development (Hemsey et al., 2001; Loumaye and 
O’Dea, 2002) when endogenous LH secretion is absent. Sufficient LH supply can be 
delivered by a daily injection of 75 IU rLH (European Recombinant Human LH Study 
Group, 1998). 
This has given rise to the concept of an ‘LH ceiling’, which defines an upper limit of 
stimulation (Messinis et al., 2010; Palermo et al., 2007).  
The physiological relevance of the ability of LH to arrest follicular growth is potentially 2‐
fold. The most obvious is the response to the mid‐cycle LH surge. Within hours after the 
onset of the surge, granulosa cell mitosis stops, the oocyte resumes meiosis and 
cumulus oophorus cells undergo functional and morphological changes in advance of 
Fig. 2.Thecal and granulosa cells interactions (from Fauci et al., 17
th
 Edition Harrison’s 
Principles of Internal Medicine) 
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ovulation (Shoham et al., 1995). The pathological relevance of this effect has been 
demonstrated in patients undergoing IVF, who had undergone an attenuated LH surge 
prior to the time of oocyte recovery. This leads to low fertilization rate and reduced 
embryo viability (Howles et al., 1986; Howles, 1990; Loumaye, 1990). 
A second possible physiological role for LH is through its contribution to follicle 
dominance and mono‐ovulation. During the early follicular phase, multiple follicles are 
present that are able potentially to develop into pre‐ovulatory follicles under the 
influence of peri‐menstrual increase in circulating FSH. The dominance of only one such 
follicle is attributed to the declining levels of FSH during the follicular phase, which falls 
below the threshold of secondary follicles. In addition to this, the rising serum LH level 
during the late follicular phase could contribute to this selection process by inducing 
secondary follicle growth arrest. If effective, this LH property could be exploited 
clinically to promote mono‐ovulation when inducing ovulation in anovulatory women. 
However, no clinical data are available to support such a role for LH. 
In sum, In the gonadotropin-dependent phase of follicular development, FSH and LH 
play a crucial role in follicle differentiation and oocyte maturation under the influence of 
paracrine signals produced by the oocyte and granulosa cells. The two gonadotropins 
collaborate in the context of the ‘‘two cells–two gonadotropins’’ theory, with FSH 
leading to the selection of the dominant follicle and LH acting on the theca cells to 
stimulate the production of androgens, which represents the substrate for FSH-induced 
E2 synthesis.  
1.2. Oocyte Development 
During the menstrual cycle only a few of primary oocytes are recruited, and only one 
matures and is ovulated. When this secondary oocyte enters meiosis (meiosis II), it does 
not finish but is arrested again and held at the metaphase II (MII) stage until fertilization. 
The MII-stage oocyte has the potential to be fertilized. When the oocyte is fertilized, the 
process of meiosis is terminated and the second polar body is extruded. During the 
menstrual cycle only 15-20 early antral follicles/oocytes are recruited and only one 
dominant follicle matures fully and is ovulated. Each oocyte develops and matures in the 
functional unit of the ovary - the follicle. The primary oocytes grow and mature during 
the development and maturation of primordial, primary and secondary follicles, 
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whereas the secondary oocytes develop along with the tertiary and preovulating 
Graafian follicle [Figure 3]. 
 
Fig. 3. Oocyte Development (from Pearson Education Inc.) 
During oocyte growth a variety of maternally transcribed mRNAs are supplied which 
represent the maternal contribution to the oocyte and, consequently, the newly 
fertilized oocyte, zygote, and early embryo. 
These mRNAs can be stored in message ribonucleoprotein (mRNP) complexes and then 
translated when needed (Hafidh et al., 2011.) 
The expression of several genes was related to apoptosis, cell cycle, circadian rhythms, 
cytoskeleton, secretory pathways, exocytosis, endocytosis, kinases, membrane 
receptors, ion channels, mitochondria, structural nuclear proteins, phospholipases, 
protein degradation, protein synthesis, secreted proteins, signaling pathways, DNA, 
chromatin, RNA, transcription, and others. 
The genes up-regulated in human oocytes were related to RNA, DNA, protein 
metabolism, and chromatin modification. The overexpression of genes associated with 
RNA metabolism is in agreement with the fact that oocytes store a great amount of RNA 
to support the processes of fertilization, early embryonic development, and activation of 
the embryonic genome. The up-regulation of genes related to DNA metabolism, 
transcription regulation (zinc finger proteins), and chromatin modification is in 
agreement with the oocyte need to remodel the sperm chromatin after fertilization. 
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The human oocyte is proposed to be transcriptionally silent at the MII stage of maturity 
but is very active in transcription and translation during the growth phase and must be 
prepared to initiate transcription during embryonic genome activation at the 4- to 8-cell 
embryo stage. 
1.3. Mature Cumulus Oocyte Complex 
The mature cumulus oocyte complex (COC) is made up of the secondary oocyte, which is 
arrested at metaphase II following extrusion of the first polar body (PB), and 
surrounding cumulus cells (CCs). 
CCs possess highly specialized trans-zonal cytoplasmic projections that pierce through 
the zona pellucida and form gap junctions at their tips with the oocyte (Albertini et al., 
2001). This intimate association allows CCs to fulfill vital roles, supporting the 
maturation of the oocyte and relaying endocrine and other environmental signals. 
CCs originate from relatively undifferentiated granulosa cells (GCs). GCs are the primary 
cell type in the ovary that provides the physical support and microenvironment required 
for the developing oocyte. 
They are actively differentiating with several distinct populations during 
folliculogenesis—from a primordial (squamous type) stage of development through 
ovulation (cuboidal type) to a luteal stage of development (hypertrophied lutein cells). 
The distinct switch from primordial to primary follicle is accompanied by a change in the 
GCs’ morphology from squamous to cuboidal type (Lintern- Moore and Moore, 1979). 
The regulation of GC cyto-differentiation thus requires the actions of a number of 
hormones and growth factors (Skinner, 2005). 
In humans and all other mammals, CCs undergo extensive proliferation prior to LH 
surge, and following the pre-ovulatory LH surge a cascade of events is initiated that 
leads to further CC proliferation and expansion (Lin et al., 2009; Scherzer et al., 2009). 
The competence to undergo expansion is a unique characteristic of CC differentiation 
(Diaz et al., 2006), which has been shown to be critical for normal oocyte development, 
ovulation and fertilization (Elvin et al., 1999; Chang et al., 2002; Vanderhyden et al., 
2003). 
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The nutritional support and trafficking of macromolecules that this system allows may 
be particularly important for oocytes due to the avascular nature of the granulosa layer 
(Johnson, 2007). 
The signalling between the CCs and oocyte via cytoplasmic processes penetrating the 
zona pellucida and forming gap junctions at the oocyte surface is a key means of 
disseminating local and endocrine signals to the oocyte (Albertini et al., 2001). 
The communication between CCs and oocyte is bi-directional, and it is clear that the role 
of the oocyte extends far beyond its functions in the transmission of genetic information 
and supply of raw materials to the early embryo. It also has a critical part to play in 
mammalian follicular control and the regulation of oogenesis, ovulation rate and 
fecundity (Eppig 2001; McNatty et al., 2004; Gilchrist and Thompson, 2007). 
Therefore, because CCs interact so closely with the oocyte and share the same 
microenvironment, they may retain a footprint of the follicular conditions experienced 
by the oocyte (Patrizio et al., 2007). The perception that CCs have a central role in the 
communication of signals within the follicle and in the support of oocyte maturation has 
led various groups to focus their research on the analysis of CC gene expression, in the 
hunt for novel markers of oocyte competence and pregnancy outcome (Cillo et al., 2007; 
Feuerstein et al., 2007; Fragouli et al., 2007; Gasca et al., 2007; Assou et al., 2008; Hamel 
et al., 2008; Van Montfoort et al., 2008; Wells et al., 2008). 
1.4. Controlled Ovarian Hyperstimulation 
Controlled ovarian hyperstimulation as used in women undergoing IVF procedures aims 
at inducing multiple follicular growth by increasing the circulating concentrations of FSH. 
According to the “two cells–two gonadotropins’’ theory, it is evident that both FSH and 
LH are required for normal follicular oestradiol biosynthesis. However, it is commonly 
believed that resting concentrations of circulating LH are sufficient to support 
development and maturation of follicles and oocytes in normogonadotrophic women 
(Chappel and Howles, 1991). 
In women undergoing IVF protocols with GnRH analogues, endogenous LH and FSH 
levels are suppressed and the induction of multiple follicular development is obtained 
by highly purified urinary or recombinant FSH. 
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This combination results in concentrations of circulating LH that are much lower than 
during the follicular phase of the normal menstrual cycle. The reasons for this are that 
the pure FSH preparations—in contrast to the classical urinary human menopausal 
gonadotrophins (hMG)—are devoid of LH activity, and that the GnRH analogue more or 
less prohibits pituitary release of endogenous LH. These low concentrations of LH lead 
to a reduced thecal production of androgen precursors, and consequently to a reduction 
of ovarian oestradiol biosynthesis, as shown in a number of clinical studies (Fleming et 
al., 1996; Westergaard et al., 1996; Agrawal et al., 1998). 
Clinical studies in women with hypogonadal hypogonadism have shown that while 
follicular development can be achieved by stimulation with pure FSH preparations, 
concentrations of circulating oestradiol and fertilization rates of retrieved oocytes are 
severely compromised compared to stimulation with preparations containing LH activity 
(Shoham et al., 1991; Balasch et al., 1995). Similarly, in normogonadotrophic women 
treated with GnRH analogues and highly purified FSH, oestradiol negatively affects 
oocyte maturation, embryo development and ability to implant (Fleming et al., 1998) 
Although the role of supplementation with LH during COH is still debated, a lots of 
studies on oocytes and pre-embryos from women with low and normal LH 
concentrations are needed to evaluate whether the nuclear maturation is insufficient, or 
whether the intrafollicular cytoplasmic maturation is suboptimal (Alviggi et al., 2011; 
Alviggi et al., 2012; Bosch et al., 2011; Hill et al., 2012a; Hill et al., 2012; Humaidan et al., 
2004; Matorras et al.,2009; Wong et al., 2011).  
 LH activity can be provided in the forms of: human menopausal gonadotrophins (hMG) 
or recombinant LH (rLH). Postmenopausal urinary extract (hMG) contains both FSH and 
LH at a fixed 1:1 combination of 75 IU FSH and 75 IU LH-like activity, mainly generated 
by u-hCG present in the urinary preparation (Bassett et al., 2009; Giudice et al., 2001; 
van de Weijer et al., 2003; Wolfenson et al., 2005).  
r-hLH, a pure molecule that can be administered alone or in association with FSH at 
different or fixed ratios (2:1) (de Placido et al., 2008; Dhillon et al., 2008; Humaidan et 
al., 2008; Nyboeandersen et al., 2008).  
However, there are only a few studies evaluating the effects of different LH activity 
sources either in terms of pregnancy rate, gonadotropin consumption, and implantation 
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rate (Buhler et al.,2011) or by investigating the molecular and biologic parameters in 
follicle cells (Grondahl et al.,2009). 
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Chapter 2  
Experimental study 
 
 
 
2.1. Background 
CCs play a major role in the development of a competent gamete and they are 
biologically distinct from other follicular cells and perform specialized roles. Surrounding 
the oocyte to form the cumulus-oocyte complex (COC), these cells are involved in a 
bidirectional communication mediated by signaling molecules produced by both germ 
and somatic components (Albertini et al., 2001; Gilchrist et al., 2008). They coordinate 
follicular development with oocyte maturation, provide energy substrates for oocyte 
meiotic resumption, regulate oocyte transcription, and stimulate amino acid transport 
and sterol biosynthesis (Assou et al., 2006; Diaz et al., 2007; Eppig et al., 2005). Finally, 
CCs respond to ovulation induction with expansion and ensure a stable and protective 
environment for the oocyte by expressing neuronal and immune response-related genes 
(Hernandez-Gonzalez et al., 2006). Because CCs interact so closely with the oocyte and 
share the same microenvironment, CC mRNA analysis may provide an indication of the 
microenvironment that the oocyte is exposed to during the final stages of its 
maturation, thus revealing prognostically relevant information concerning its biological 
competence (Fragouli et al., 2012; Huang et al., 2010). 
Overall, these studies provide evidence for a dissimilar biologic status in follicle cell 
components after different stimulation regimens. It has been reported that hCG, the LH-
activity present in hMG, generates LHR downregulation in mural granulosa cells (GCs) 
compared with FSH stimulation alone (Grondahl et al., 2009). This effect, originally 
assessed in a rat model, was shown to be mediated by the activation of the mitogen-
activated protein kinase pathway (Menon et al., 2006; Menon et al., 2010). 
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Moreover, a different profile of gene expression has been found in GCs after stimulation 
protocols with hMG or FSH alone. Among the genes differentially expressed in these 
conditions, several had known relevance to oocyte maturation, such as BMPR2, a 
receptor for oocyte-derived factors, GDF-9, and BMP-15, which was found to be down-
regulated in hMG-stimulated GCs compared with r-hFSH–stimulated GCs (Brannian et 
al., 2010). 
2.2. Experimental Design 
To the best of our knowledge, the evaluation of CC biologic status after different 
stimulation protocols containing various LH activities compared with FSH alone has not 
been carried out. Nevertheless, it is reasonable to hypothesize that LH and hCG, though 
challenging the same receptor, may lead to different downstream signaling pathways in 
cumulus or granulosa cells. Evidence that cumulus cells have a central role in the 
development of oocyte competence, together with the limited knowledge about follicle 
differentiation induced by different LH sources, led us to investigate whether 
gonadotropin regimens for controlled ovarian stimulation affect the gene expression in 
these cells. To this aim, DNA microarray technology was used to analyze the gene 
expression profile in CCs obtained from ART patients receiving urinary or recombinant 
gonadotropin preparations containing both FSH and LH activities from different sources 
(recombinant molecules or u-hCG) compared with recombinant preparations of FSH 
alone (r-hFSH). Differential gene expression under different stimulation regimens was 
taken as evidence of modifications in signaling and metabolic pathways that could 
potentially affect oocyte quality. 
2.3. Materials and Methods 
COC were collected at the IVF laboratories of the University of Pisa and the Cannizzaro 
Hospital of Catania. Sixteen healthy women aged <35 years with normal BMI (18.5–24.9 
kg/m2), FSH <8 pg/mL, antral follicle count >7, and regular cycles who had been referred 
to IVF or ICSI treatment for male-factor infertility, tubal disease, or unexplained 
infertility participated in the study after providing written informed consents. The study 
was approved by the local Ethical Committees and performed in compliance with the 
Declaration of Helsinki. The study was also carried out under the supervision of the 
Italian Society of Embryology and Reproduction. All patients were down-regulated with 
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daily GnRH agonist (Enantone die®; Takeda Pharmaceutical Co.). Four of the 16 patients 
received 225 IU hp-hMG daily, as 225 IU FSH plus 225 IU LH-like activity (Meropur®; 
Ferring Pharmaceuticals), and four received 150 IU r-hFSH plus 75 IU r-hLH daily 
(Pergoveris®; Merck Serono). The control group was represented by eight patients that 
received r-hFSH (Gonal F®; Merck Serono), at a daily dose fixed at 225 IU. All of the 
patients received gonadotropin treatment for a maximum of 12 days, and ovulation was 
induced by a single administration of hCG (10,000 IU; Gonasi®; IBSA) on the day after 
the last hp-hMG, r-hFSH plus r-hLH, or r-hFSH alone, when the leading follicle had 
reached a mean diameter of 17 mm. 
Aspiration of the oocytes was performed transvaginally by ultrasound guidance 36 hours 
after hCG administration. 
2.3.1 Cumulus Cell Collection 
After follicular aspiration, collected COCs were immediately washed in HEPES-buffered 
medium (Cook). CCs were dissected with the use of a sterile scalpel and transferred 
immediately into a sterile tube containing 50 mL RNAprotect Cell Reagent (Qiagen) and 
stored at -80°C for further analysis. Only samples derived from COCs containing mature 
oocytes showing polar body were processed. 
2.3.2 mRNA Extraction and Microarray Analysis 
Total RNA was extracted from CCs with the use of the Picopure RNA Isolation Kit (MDS 
Analytical Technologies). 
The purity and quantity of RNA was assessed with the use of an Agilent 8453 
Spectrophotometer (Agilent). Extracted RNA was linearly amplified with the use of the 
Ambion Amino Allyl MessageAmp II aRNA Amplification Kit (Life Technologies) and 
fluorescently labeled with Cy3–Cy5 cyanins (GE Healthcare). The modified aRNAs were 
hybridized on high-density array Human Whole Genome 
OneArray Microarray V5 (30,275 total probes; Phalanx Biotech Group). Each experiment 
was carried out on RNA pools obtained by mixing the RNAs from CCs (3–5 CCs from each 
patient) of four patients treated with rLH plus rFSH, four patients treated with hp-hMG, 
and eight patients treated with r-hFSH alone, for a total of six experiments (three 
biologic and three technical replicates). After hybridization, cyanin fluorescent signals 
were captured by a Confocal Laser Scanner (Scanarray Express; Perkin Elmer) and 
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analyzed with the use of the Scanarray Express Microarray Analysis System version 3.0 
software (Perkin Elmer). Signal analysis was assessed as described by Gatta et al. (Gatta 
et al., 2010). For each slide, after local background subtraction, a LOWESS algorithm was 
used for row data normalization to evaluate signal-to-noise ratio and generate log ratios 
of sample versus reference signal. Analysis of data obtained by microarray experiments 
was carried out by means of hierarchic gene clustering with the use of Cluster 3.0 (open 
source 2006) and Treeview (Stanford University Labs) software. In the clustering 
analysis, transcripts were entered that showed an absolute log ratio value of ≥0.5 or ≤-
0.5, an index that translates into a 1.4-fold change in transcript quantity. In the cluster 
analysis we took into account only spots showing a measurable expression in ≥80% of 
experiments and being >1.7-fold up- or down-regulated. Gene biologic functions were 
inferred with the use of Ingenuity Pathways Analysis (IPA) software (Ingenuity Systems). 
The listing of significant differential expression genes related to both experimental 
conditions (r-hLH plus r-hFSH versus r-hFSH and hp-hMG versus r-hFSH) was performed 
by considering a transcript to be significantly differential expressed when showing an 
absolute log-ratio as described above and presenting measurable expression value in all 
experiments. 
2.3.3 Real-Time PCR  
Microarray results for a subset of genes (MAPK6, AKT3, DNase I, RXRB, IL11and RAD50) 
were verified by quantitative reverse-transcription polymerase chain reaction (qRT-PCR). 
One microgram of each RNA pool was reverse transcribed to cDNA (high-capacity cDNA 
reverse transcription kit; Applied Biosystems), and qRT-PCR was carried out in a total 
volume of 30 mL containing 1_ Taqman Universal PCR Master Mix, no Amperase UNG 
(Applied Biosystems), and 2 mL cDNA, with the use of the Prime Time Mini qPCR Assay 
(Integrated DNA Technologies) on an ABI 7900HT Sequence Detection System (Applied 
Biosystems). Triplicate samples were run for each gene. The housekeeping gene GAPDH 
was used as an internal control to normalize the expression of target genes. Relative 
expression levels were calculated for each sample after normalization against GAPDH, 
with the use of the DDCt method for comparing relative fold expression differences, as 
previously described (Livak et al., 2001). 
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Chapter 3  
Results  
 
 
 
COCs were isolated from eight patients treated with r-hFSH, four patients treated with 
hp-hMG, and four patients treated with r-hLH plus r-hFSH. The registered basal 
parameters of the patients are reported in Table (below). 
 
To gain insights on the global changes in gene expression of CCs obtained from women 
treated for ovarian stimulation with r-hLH plus r-hFSH or hp-hMG versus r-hFSH alone 
(control subjects), we carried out a hierarchic clustering analysis of the dataset 
originated from a total of six experiments (three biologic and three technical replicates). 
After the evaluation of the six experiments, transcript expression was analyzed to select 
genes significantly up and down-expressed. On a total of 30,275 investigated transcripts, 
microarray analysis showed the presence of four specific clusters containing genes 
differentially expressed in the different conditions.  
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The first cluster (cluster 1, Fig. 4) is composed of 84 genes down-regulated after 
stimulation with hp-hMG and up-regulated after r-hLH plus r-hFSH administration 
compared with control. The second cluster (cluster 2, Fig. 4) involves 61 transcripts 
down-regulated after the use of r-hLH plus r-hFSH and up-regulated after treatment 
with hp-hMG compared with control.  
 
Fig 4 Hierarchic clustering analysis of 
the dataset originated from a total of 
six experiments carried out on RNA 
extracted from cumulus-oocyte cells 
obtained from women treated for 
ovarian stimulation with r-hLH þ r-
hFSH or hp-hMG versus r-hFSH alone 
(control). (Gatta V et al., 2013) 
 
 
 
 
 
 
 
 
 
 
EVALUATION OF CUMULUS CELLS TRANSCRIPTOME IN PATIENTS UNDERGOING IN VITRO FERTILIZATION PROCEDURES TREATED 
WITH DIFFERENT CONTROLLED OVARIAN STIMULATION PROTOCOLS 
20 
 
  
Fig 5.  IPA functional analysis of the Cluster 1: genes down-regulated after stimulation with hp-
hMG and up-regulated after r-hLH plus r-hFSH. 
 
 
 
The remaining two clusters is composed of genes showing a similar profile after both 
stimulation protocols, 53 genes being up-regulated (cluster 3, Fig. 4) and 11 genes being 
down-regulated (cluster 4, Fig. 4) compared with control.  
 
Fig 6. IPA functional analysis of the Cluster 2: genes down-regulated after the use of r-
hLH plus r-hFSH and up-regulated after treatment with hp-hMG compared with control 
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Fig 7. IPA functional analysis of the Cluster 3: genes up-regulated in both groups 
 
 
Fig 8. IPA functional analysis of the Cluster 4: genes down-regulated in both groups 
 
IPA analysis, performed to highlight the main functions and cellular processes in which 
these clusters of genes are involved, found that the genes present in cluster 1 were 
mainly involved in the following cellular functions: gene expression, cell-to-cell signaling 
and interaction, cellular growth and proliferation, cell cycle, morphology, and death, 
inflammatory response, and molecular transport [Fig. 5]. Genes in cluster 2 play central 
roles in functions related to inflammatory response, cellular functions, organization, 
assembly, maintenance, growth and proliferation, cell cycle, death, morphology, and 
signaling, molecular transport, embryonic development, and DNA replication, 
recombination, and repair [Fig. 6].  
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Genes in cluster 3 are involved in functions such as cell cycle and death, cell-to-cell 
signaling and interaction, cellular function, maintenance, growth, development, and 
proliferation, inflammatory response, gene expression, molecular transport, lipid 
metabolism, and protein trafficking [Fig. 7]. Finally, genes in cluster 4 appear to be 
implicated in damage processes probably due to the exogenous molecule administration 
[Fig. 8]. 
IPA analysis was also used to highlight the networks in which the genes present in the 
different clusters are involved. Three networks with a score ranging from 30 to 23 (data 
not shown) were found in cluster 1, composed of genes involved in the retinoic acid 
trafficking (RXRB, TTR, ALDH8A1), phosphatase activity (PPP1R14D, PPM1A), 
sulfotransferase pathway (SULT1A1, CHST2), inflammatory response (COX11, IL11, 
UMOD), mitochondrial oxidative respiratory chain (COX11, MRPL12, BBOX1), and DNA 
methylation (MDB4, WBSCR22). [Fig. 9].   
 
Fig 9. Network generated by Ingenuity Pathways Assessment analysis associated with the cluster 
1. Genes in gray are down-regulated after the use of r-hLH þ r-hFSH and up-regulated after 
treatment with hp-hMG compared with control. Genes in white are not modulated by 
treatments. Arrows indicate that a molecule acts on another, and lines without arrows indicate 
that a molecule binds to another. (Gatta V et al., 2013) 
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Cluster 2 showed the presence of genes involved in transcription regulation (MAPK6), 
proliferation and hormone synthesis (PPARA, PTFAR), DNA damage and repair (DNaseI, 
RAD50), and DNA transcription regulation (PPARA, PTFAR, MMP12, ZBT7A, SOCS4, 
SNURF4). Cluster 3, characterized by the presence of 53 genes up-regulated by both 
treatments, showed the presence of a small number of genes, such as IFNB1, MIER1, 
FOXJ2, RNF141, and ZFHX3, involved in the regulation of transcription and affecting 
several cellular processes, such as cell cycle, growth, and proliferation. 
However, the global up-regulation of the transcripts present in this cluster suggests that 
the administration of both r-hLH plus r-hFSH and hp-hMG could alter a portion of the CC 
transcriptome compared with treatment with r-hFSH alone. Finally, cluster 4, containing 
11 transcripts down-regulated in both stimulation protocols, included genes involved in 
COC expansion and cell-to-cell interaction (CLCN6, SLC19A2). 
The analysis of significant differential expression genes related to both experimental 
conditions showed 333 and 163 genes, respectively, up- and down-regulated in r-hLH 
plus r-hFSH versus rFSH and 2,190 and 1,179 genes, respectively, up- and down-
regulated in hp-hMG vs. rFSH. These data are not discussed here, because in the present 
study we focused our attention on the comparison of the treatment effects on CC gene 
expression by cluster analysis. 
To validate the microarray results, qRT-PCR was performed on the three different pools 
of RNA extracted from the CCs of patients treated with the different protocols. The 
analysis of selected genes that were related to oocyte maturation and showed a 
differential expression in the two treatments (AKT3, IL11, and RXRB in cluster 1; DNase, 
MAPK6, and RAD50 in cluster 2) produced, in all cases, results in agreement with the 
data obtained by the microarray assay on the same transcripts. 
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Chapter 4  
Discussion and Conclusions 
 
 
 
4.1. Discussion 
The analysis of the CC expression profiles after treatment with r-hLH plus r-hFSH or hp-
hMG (containing u-hCG as LH-like activity) revealed that, compared with r-hFSH alone, 
the two types of stimulation protocol activate different intracellular pathways in CCs, 
promoting the differential expression of 145 genes grouped in two clusters (clusters 1 
and 2), in the periovulation phase. Because the two pharmaceutical preparations mainly 
differ in the LH source (r-hLH or u-hCG), but act on the same cell surface receptor (LHR), 
it can be hypothesized that this activity probably involves different mechanisms of 
interaction between the two active molecules, LH and hCG, and their receptor, inducing 
a differential gene expression. The differentially expressed genes, evaluated at the 
periovulation phase, were represented by four different gene clusters, each containing 
transcripts critically involved in growth, development, and communication between cells 
and representing central processes for the oocyte maturation and its maintenance. 
The larger cluster (cluster 1) contains 84 genes down-regulated after hp-hMG and up-
regulated after r-hLH plus r-hFSH treatment compared with control (r-hFSH alone). 
The first network associated with this cluster [Fig. 9] is characterized by the presence of 
three genes linked to retinoic acid trafficking, namely RXRB, TTR, and ALDH8A1. RXRB is 
a nuclear receptor that regulates transcriptional activity after its interaction with 
retinoic acid (He et al., 2009; Mohan et al., 2003); TTR belongs to a protein cluster 
involved in thyroid hormones and retinoic acid transport (Schweigert et al., 2006); and 
ALDH8A1 is a dehydrogenase that converts retinoic acid into its active form which 
interacts with RXRB (Zhuang et al., 2002). Retinoic acid is an important mediator of 
EVALUATION OF CUMULUS CELLS TRANSCRIPTOME IN PATIENTS UNDERGOING IN VITRO FERTILIZATION PROCEDURES TREATED 
WITH DIFFERENT CONTROLLED OVARIAN STIMULATION PROTOCOLS 
25 
 
estrogen activity (Koda et al., 2007), regulating the activation of female hormones 
through sulfotransferase, which targets estrogens and determines their reactivation. 
Interestingly, also present in the same network are two genes encoding for other 
enzymes involved in sulfotransferase activity, SULT1A1 and CHST2. Other interesting 
evidence is the down-regulation of two genes encoding for phosphatase enzymes 
(PPP1R14D and PPM1A) in the hp-hMG group, playing a key role in protein 
dephosphorylation and regulating the cellular cycle and growth, essential for CC 
expansion and oocyte maturation through the activation of proteins involved in mitosis 
(Regassa et al., 2011). In this cluster map are also WBSCR22, DCAF6, and MBD4, which 
are all linked to DNA methylation and transcription regulation (Huntriss et al., 2004; 
Nakazawa et al., 2011), CPSF4, which is involved in mRNA polyadenilation, and MRPL12, 
which is involved in mitochondrial synthesis of proteins (Wang et al., 2007). Finally, this 
cluster shows the presence of IL11, which plays a central role in the process of oocyte 
and follicle development (Sanchez-Cuenca et al., 1999), AKT3, which is linked to the 
intracellular pathway PIK3/ AKT, which regulates female fertility and oocyte 
development to prevent apoptosis and promote embryo development and survival, and 
NFIB, which is a transcription regulator whose down-regulation represents a good 
prognostic factor in COCs leading to a positive pregnancy outcome after IVF (Brown et 
al., 2010). 
The second cluster (cluster 2) contains 61 genes down-regulated after the use of r-hLH 
plus r-hFSH and up-regulated after treatment with hp-hMG compared with control. 
This cluster shows the presence of MAPK6, a gene whose activity is essential in 
transcription regulation through protein phosphorylation and cross-talk between oocyte 
and cumulus cells, leading to cell growth and development (Sasseville et al., 2010). 
Other genes present in cluster 2 and playing a crucial role in the ovulation process are 
PTFAR and PPARA. PTFAR regulates kinasic fall and cell growth (Tiemann et al., 2008), 
and PPARA is a nuclear receptor involved in hormone synthesis and glucose and lipid 
metabolism, whose overexpression is negatively related to estrogen synthesis acting on 
aromatase, an enzyme involved in E2 metabolism (Komar et al., 2000). PPARA and 
PTFAR, together with other genes whose expressions are altered after the treatments, 
such as MMP12, ZBT7A, and SOCS4, are involved in gene expression regulation 
(Sandberg et al., 2006). Finally, cluster 2 also shows the presence of SNURF4, a gene 
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encoding for a protein that binds to LH promoter in rising chromatin, regulating its 
transcription (Curtin et al., 2004). 
Cluster 3 shows the presence of 53 genes up-regulated after both treatments compared 
with control. The majority of these genes are not directly related to oocyte and CC 
function, but could explain a certain alteration sustained by the cells after treatments, 
especially affecting transcription regulation. Among these, IFNB1 is a negative regulator 
of interleukin production, inhibiting their proliferative signals (Konat et al., 2009). MIER1 
was initially described as a growth factor but is now known to be linked to histone 
acetylation repression, leading to decreased gene transcription (Blackmore et al., 2008). 
FOXJ2 is a specific transcription regulator expressed in granulosa cells and in the early 
preimplantation embryo (Granadino et al., 2000). RNF141 is a zinc finger gene that 
seems to play important roles in the early development of embryos and which was 
already described in male gametes (Deng et al., 2009). ZFHX3 encodes for a transcription 
regulator but also has inhibitory activity on estrogen receptors, thus playing a role in CC 
proliferation and oocyte development (Dong et al., 2010). 
Finally, in cluster 4 only four out of 11 genes present appear to be related to oocyte 
development and CC expansion. 
CLCN6 encodes for a membrane chloride channel that is mainly expressed during oocyte 
development (Falin et al., 2009). SLC19A2 (Kumar et al., 1998) encodes for a folic acid 
carrier, and its down-expression could be related to a block of oocyte development and 
growth. PIP4K2A encodes for a nuclear protein that has a role in chromosome structure 
maintenance (Hinchliffe et al., 1999). Finally, the down-regulation of PDSS2, which is 
involved in the production of coenzyme Q10 in mitochondria, suggests possible damage 
in the respiratory chain (Saiki et al., 2005). 
4.2. Conclusions 
The study of expression profiling of CCs of women treated with different stimulation 
protocols provided evidence that, although performing their activity on the same 
receptor, r-hLH plus r-hFSH and hp-hMG produce different effects in terms of regulation 
of gene expression, as evidenced by the presence of gene clusters showing up- or 
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downregulation depending on the stimulation protocols compared with the expression 
levels detected after r-hFSH treatment. 
This suggests that the effect of the two molecules at the intracellular level is likely 
mediated by different binding affinity of the two molecules with the receptor, leading in 
turn to the activation of different pathways. Our data are in agreement with an earlier 
report on granulosa cells after stimulation with r-hFSH and hp-hMG showing differential 
expression of 85 genes (Grondahl et al., 2009). This suggests that the different hormone 
composition of the two drugs affects the expression of genes playing a crucial role in 
periovulatory events and could influence the developmental competence of the oocyte 
and corpus luteum function. In this regard, the finding that the molecular phenotype of 
CCs is strongly influenced by gonadotropin stimulation highlights the need for further 
investigations aimed to evaluate biologic and molecular effects on oocyte maturation. 
The clinical question to ask is whether the differences shown have any implications for 
the unselected IVF population. According to the most recent Cochrane analysis by Al 
Inany et al. (van Wely et al., 2012), no difference in live birth rate was seen when 
comparing rFSH with FSH and LH ‘‘activity’’; however, significantly more oocytes were 
retrieved with rFSH, most probably because of differences in the isoform profile. In 
contrast, another recent metaanalysis (Hill et al., 2012) showed a significant increase in 
clinical pregnancy rate in favor of rFSH plus rLH versus rFSH only in patients >35 years of 
age. 
Further studies are needed to better understand the effect on gene expression of 
different controlled ovarian hyperstimulation protocols and to provide a personalized 
treatment for patients. 
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